{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:59:06Z","timestamp":1789732746821,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.diagmicrobio.2008.02.008","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T12:24:14Z","timestamp":1207225454000},"page":"86-95","source":"Crossref","is-referenced-by-count":86,"title":["Antimicrobial activity of ceftobiprole, a novel anti\u2013methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005\u20132006)"],"prefix":"10.1016","volume":"61","author":[{"given":"Thomas R.","family":"Fritsche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helio S.","family":"Sader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-0691.2006.01402.x","article-title":"MRSA\u2014the tip of the iceberg","volume":"12","author":"Appelbaum","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.mib.2005.07.001","article-title":"Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria","volume":"8","author":"Appelbaum","year":"2005","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib3","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1128\/AAC.00044-06","article-title":"Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis","volume":"50","author":"Bogdanovich","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib4","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1128\/AAC.49.10.4210-4219.2005","article-title":"Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin","volume":"49","author":"Bogdanovich","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib5","doi-asserted-by":"crossref","first-page":"55S","DOI":"10.1592\/phco.2005.25.10part2.55S","article-title":"The antimicrobial armamentarium: evaluating current and future treatment options","volume":"25","author":"Bosso","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1517\/13543784.16.4.419","article-title":"Anti-MRSA \u03b2-lactams in development, with a focus on ceftobiprole: the first anti-MRSA \u03b2-lactam to demonstrate clinical efficacy","volume":"16","author":"Bush","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2008.02.008_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-0691.2006.01404.x","article-title":"Ceftobiprole: in-vivo profile of a bactericidal cephalosporin","volume":"12","author":"Chambers","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib8","series-title":"M7-A7, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard\u2014Seventh Edition","author":"Clinical and Laboratory Standards Institute","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib9","series-title":"M45-A. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria","author":"Clinical and Laboratory Standards Institute","year":"2006"},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib10","series-title":"M100-S17, Performance Standards for Antimicrobial Susceptibility Testing, 17th Informational Supplement","author":"Clinical and Laboratory Standards Institute","year":"2007"},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib11","series-title":"M100-S18, Performance Standards for Antimicrobial Susceptibility Testing, 18th Informational Supplement","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib12","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1128\/JCM.02311-06","article-title":"Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection","volume":"45","author":"Davis","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib13","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1128\/AAC.00272-06","article-title":"In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals","volume":"50","author":"Denis","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diagmicrobio.2004.04.011","article-title":"Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates","volume":"50","author":"Deshpande","year":"2004","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib15","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1046\/j.1469-0691.2003.00765.x","article-title":"Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococci","volume":"9","author":"Deshpande","year":"2003","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1592\/phco.27.2.227","article-title":"Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections","volume":"27","author":"Drew","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.diagmicrobio.2006.10.015","article-title":"Antianaerobe activity of ceftobiprole, a new broad-spectrum cephalosporin","volume":"58","author":"Ednie","year":"2007","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib18","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1128\/AAC.00722-06","article-title":"In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections","volume":"50","author":"Goldstein","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.diagmicrobio.2003.09.006","article-title":"In vitro activity of BAL9141 against clinical isolates of gram-negative bacteria","volume":"48","author":"Issa","year":"2004","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2008.02.008_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1469-0691.2007.01722.x","article-title":"In-vitro profile of a new \u03b2-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus","volume":"13","author":"Jones","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib21","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/jac\/dkf249","article-title":"In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci","volume":"50","author":"Jones","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7326\/0003-4819-144-5-200603070-00005","article-title":"Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections","volume":"144","author":"King","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib23","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/AAC.49.5.1932-1942.2005","article-title":"Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin","volume":"49","author":"Kosowska","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib24","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1128\/AAC.48.8.2831-2837.2004","article-title":"In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci","volume":"48","author":"Kurazono","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2008.02.008_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1469-0691.2006.01403.x","article-title":"Can \u03b2-lactams be re-engineered to beat MRSA?","volume":"12","author":"Livermore","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"issue":"Suppl 2","key":"10.1016\/j.diagmicrobio.2008.02.008_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2007.01725.x","article-title":"Clinical profile of ceftobiprole, a novel \u03b2-lactam antibiotic","volume":"13","author":"Noel","year":"2007","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/AAC.00551-07","article-title":"Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by Gram-positive bacteria","volume":"52","author":"Noel","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib28","doi-asserted-by":"crossref","first-page":"3089\u20133095","DOI":"10.1128\/AAC.00218-07","article-title":"Interactions of ceftobiprole with \u03b2-lactamases from molecular classes A to D","volume":"51","author":"Queenan","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib29","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/AAC.01351-07","article-title":"Antimicrobial activity of ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA)","volume":"52","author":"Sader","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl 3","key":"10.1016\/j.diagmicrobio.2008.02.008_bib30","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1086\/519473","article-title":"Epidemiology of staphylococcal resistance","volume":"45","author":"Shorr","year":"2007","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl 4","key":"10.1016\/j.diagmicrobio.2008.02.008_bib31","doi-asserted-by":"crossref","first-page":"S269","DOI":"10.1086\/430788","article-title":"Community-associated methicillin-resistant Staphylococcus aureus","volume":"41","author":"Weber","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/jac\/49.3.535","article-title":"BAL 9141, a new broad-spectrum pyrrolidinone cephalosporin: activity against clinically significant anaerobes in comparison with 10 other antimicrobials","volume":"49","author":"Wootton","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.diagmicrobio.2007.06.023","article-title":"Activity of ceftobiprole against community-associated methicillin-resistant Staphylococcus aureus isolates recently recovered from US military trainees","volume":"59","author":"Yun","year":"2007","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2008.02.008_bib34","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/AAC.46.3.872-875.2002","article-title":"In vitro activities of BAL9141, a novel broad-spectrum pyrrolidinone cephalosporin, against Gram-negative nonfermenters","volume":"46","author":"Zbinden","year":"2002","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889308001442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889308001442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T15:25:23Z","timestamp":1546183523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889308001442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0732889308001442"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2008.02.008","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}